CORTIAZEM RETARD
Modified-release tablet, 90 mg
RxActive license
Active substance (INN)
diltiazem
Pharmaceutical form
Pharmaceutical formModified-release tablet
Strength90 mg
PackagingUkupno 30 tableta sa modifikovanim oslobađanjem u blisteru (3x10) u kartonskoj kutiji
ManufacturerHemofarm a.d. Vršac, Serbia
Therapeutic groupCardiovascular system (C08DB01)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateJune 23, 2016
Analogs in Montenegro
1Other medicines with the same active substance
Source: CInMED register